Pramlintide (Symlin) clinical trials: 29 trials
Page 1 of 1
Read 29 Pramlintide (Symlin) clinical trials with posted results or linked papers with results in PepBank.
- A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes
NCT00467649 · Phase 4 · Completed
Posted results
- Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
NCT01269047 · Phase 4 · Completed
Posted results
- Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia
NCT00690235 · Phase 4 · Completed
Posted results
- Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery
NCT01841359 · Phase 4 · Completed
Posted results
- Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus
NCT00442767 · Phase 4 · Completed
Posted results
- Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus
NCT00108004 · Phase 3 · Completed
Linked paper with results
- Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control
NCT00042458 · Phase 3 · Completed
Linked paper with results
- A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes
NCT00240253 · Phase 4 · Completed
Linked paper with results
- Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
NCT00107107 · Phase 3 · Completed
Linked paper with results
- The Role of Amylin and Glucagon in T1DM
NCT00206258 · Phase 3 · Completed
Linked paper with results
- Continuous Subcutaneous Infusion of Pramlintide and Insulin
NCT00291772 · Phase 4 · Completed
Linked paper with results
- A Pilot Study of Continuous Subcutaneous Pramlintide Infusion Therapy in Patients With Type 1 Diabetes
NCT00502138 · Phase 4 · Completed
Linked paper with results
- Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects
NCT00673387 · Phase 2 · Completed
Posted results
- Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin
NCT00819234 · Phase 2 · Completed
Posted results
- A Study To Examine The Efficacy And Safety Of Pramlintide+Metreleptin In Obese Subjects
NCT01235741 · Phase 2 · Terminated
Posted results
- A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects
NCT00392925 · Phase 2 · Completed
Posted results
- Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D
NCT04074317 · Phase 2 · Completed
Posted results
- A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects
NCT00112021 · Phase 2 · Completed
Linked paper with results
- A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects
NCT00189514 · Phase 2 · Completed
Linked paper with results
- A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus
NCT03981627 · Phase 1/2 · Completed
Linked paper with results
- Effect of Basal-Bolus Closed-Loop Co-Administration of Insulin and Pramlintide on Improving the Glycemic Control in Type 1 Diabetes
NCT02814123 · Phase 2 · Completed
Linked paper with results
- Insulin-plus-pramlintide Closed-loop Strategy to Regulate Glucose Levels Without Carbohydrate Counting
NCT03800875 · Phase 2 · Completed
Linked paper with results
- Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus
NCT02500979 · Phase 1 · Completed
Posted results
- Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM
NCT01708044 · Phase 1 · Completed
Linked paper with results
- An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
NCT00229658 · Phase not stated · Completed
Posted results
- Two Way Crossover Closed Loop Study Insulin vs Insulin and Pramlintide
NCT06422325 · Not applicable · Completed
Posted results
- Pramlintide in Adolescents With Type 1 Diabetes
NCT00842075 · Not applicable · Completed
Posted results
- Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial Pancreas
NCT04163874 · Not applicable · Completed
Linked paper with results
- The Effect of Pramlintide on Meal Time Insulin Bolus
NCT00460304 · Not applicable · Completed
Linked paper with results